Phreesia, Inc. (NYSE:PHR) General Counsel Sells $28,300.68 in Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 1,238 shares of the firm’s stock in a transaction on Monday, April 15th. The stock was sold at an average price of $22.86, for a total value of $28,300.68. Following the transaction, the general counsel now directly owns 135,621 shares of the company’s stock, valued at $3,100,296.06. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Phreesia Stock Performance

Shares of PHR opened at $23.16 on Thursday. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.78 and a quick ratio of 1.78. The stock has a 50-day moving average of $24.49 and a 200-day moving average of $21.25. The company has a market cap of $1.31 billion, a PE ratio of -9.19 and a beta of 0.92. Phreesia, Inc. has a one year low of $12.05 and a one year high of $34.98.

Phreesia (NYSE:PHR) last issued its earnings results on Thursday, March 14th. The company reported ($0.56) EPS for the quarter, beating the consensus estimate of ($0.58) by $0.02. The company had revenue of $95.00 million during the quarter, compared to the consensus estimate of $93.52 million. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. The firm’s revenue for the quarter was up 24.0% compared to the same quarter last year. During the same period last year, the business posted ($0.72) EPS. On average, equities research analysts predict that Phreesia, Inc. will post -1.48 EPS for the current fiscal year.

Institutional Trading of Phreesia

Large investors have recently made changes to their positions in the company. International Assets Investment Management LLC lifted its position in Phreesia by 1,987.3% in the 4th quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock valued at $34,000 after acquiring an additional 1,411 shares in the last quarter. Captrust Financial Advisors lifted its position in Phreesia by 154.6% in the 2nd quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock valued at $36,000 after acquiring an additional 866 shares in the last quarter. Acadian Asset Management LLC bought a new position in Phreesia in the 1st quarter valued at about $43,000. State of Wyoming lifted its position in Phreesia by 34.6% in the 2nd quarter. State of Wyoming now owns 1,918 shares of the company’s stock valued at $59,000 after acquiring an additional 493 shares in the last quarter. Finally, Tower Research Capital LLC TRC lifted its position in Phreesia by 85.4% in the 3rd quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock valued at $80,000 after acquiring an additional 1,445 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on PHR. Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 target price on shares of Phreesia in a research report on Friday, March 15th. Robert W. Baird increased their price target on Phreesia from $30.00 to $31.00 and gave the stock an “outperform” rating in a report on Monday, March 18th. Stephens reiterated an “overweight” rating and set a $28.00 price target on shares of Phreesia in a report on Friday, March 22nd. Barclays initiated coverage on Phreesia in a report on Wednesday, January 3rd. They set an “overweight” rating and a $29.00 price target for the company. Finally, Raymond James reiterated an “outperform” rating and set a $30.00 price target (up from $25.00) on shares of Phreesia in a report on Friday, March 15th. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $31.62.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.